"For those with a history of previous medical or surgical treatment for their endometriosis, Relugolix CT is an alternative ...

People with endometriosis could be given a new pill on the NHS which is said to be better than what's currently on offer.

Endometriosis affects millions of people - and this new breakthrough treatment could be a game-changer for some ...

The group that drafted a key blueprint for Donald Trump’s second term convened a meeting in Washington D.C. this week to ...

The National Health Service (NHS) in England has approved Gedeon Richter’s Ryeqo (relugolix + estradiol + norethisterone), ...

Initially, Nice rejected the drug’s use, but the manufacturer, Gedeon Richter, submitted additional evidence that addressed ...

A daily pill has been approved by NICE for treating some women with endometriosis after initially being rejected.

The combination drug could help around 1,000 women every year in England who suffer from the debilitating condition. | ITV National News ...

NICE estimates that 1,000 women could benefit from Ryeqo, which can be taken once-daily up until the menopause.

The NHS has approved a new pill that is designed to transform the treatment of endometriosis. The combination drug will help around 1,000 women every year in England who suffer from the debilitating ...

Ryeqo is likely to start being prescribed to patients in Wales within two months, but there will be restrictions on who can ...

Gedeon Richter's drug is the only licensed GnRH antagonist option and, unlike GnRH agonists like Takeda's Prostap ...